Copyright Reports & Markets. All rights reserved.

Covid-19 Impact on Contraceptives Drugs and Devices Market, Global Research Reports 2020-2021

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Contraceptives Drugs and Devices Industry
  • 1.7 COVID-19 Impact: Contraceptives Drugs and Devices Market Trends

    • 2 Global Contraceptives Drugs and Devices Quarterly Market Size Analysis

    • 2.1 Contraceptives Drugs and Devices Business Impact Assessment - COVID-19
      • 2.1.1 Global Contraceptives Drugs and Devices Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Contraceptives Drugs and Devices Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Contraceptives Drugs and Devices Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Contraceptives Drugs and Devices Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Contraceptives Drugs and Devices Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Contraceptives Drugs and Devices Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Contraceptives Drugs and Devices Market
    • 3.5 Key Manufacturers Contraceptives Drugs and Devices Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Contraceptives Drugs and Devices Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
      • 1.4.2 Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
    • 4.2 By Type, Global Contraceptives Drugs and Devices Market Size, 2019-2021
      • 4.2.1 By Type, Global Contraceptives Drugs and Devices Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Contraceptives Drugs and Devices Price, 2020-2021

    5 Impact of Covid-19 on Contraceptives Drugs and Devices Segments, By Application

    • 5.1 Overview
      • 5.5.1 Female
      • 5.5.2 Male
    • 5.2 By Application, Global Contraceptives Drugs and Devices Market Size, 2019-2021
      • 5.2.1 By Application, Global Contraceptives Drugs and Devices Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Contraceptives Drugs and Devices Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Teva Pharmaceutical Industries Ltd
      • 7.1.1 Teva Pharmaceutical Industries Ltd Business Overview
      • 7.1.2 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Quarterly Production and Revenue, 2020
      • 7.1.3 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product Introduction
      • 7.1.4 Teva Pharmaceutical Industries Ltd Response to COVID-19 and Related Developments
    • 7.2 Church & Dwight Co. Inc
      • 7.2.1 Church & Dwight Co. Inc Business Overview
      • 7.2.2 Church & Dwight Co. Inc Contraceptives Drugs and Devices Quarterly Production and Revenue, 2020
      • 7.2.3 Church & Dwight Co. Inc Contraceptives Drugs and Devices Product Introduction
      • 7.2.4 Church & Dwight Co. Inc Response to COVID-19 and Related Developments
    • 7.3 Reckitt Benckiser Plc
      • 7.3.1 Reckitt Benckiser Plc Business Overview
      • 7.3.2 Reckitt Benckiser Plc Contraceptives Drugs and Devices Quarterly Production and Revenue, 2020
      • 7.3.3 Reckitt Benckiser Plc Contraceptives Drugs and Devices Product Introduction
      • 7.3.4 Reckitt Benckiser Plc Response to COVID-19 and Related Developments
    • 7.4 Pfizer, Inc
      • 7.4.1 Pfizer, Inc Business Overview
      • 7.4.2 Pfizer, Inc Contraceptives Drugs and Devices Quarterly Production and Revenue, 2020
      • 7.4.3 Pfizer, Inc Contraceptives Drugs and Devices Product Introduction
      • 7.4.4 Pfizer, Inc Response to COVID-19 and Related Developments
    • 7.5 Bayer AG
      • 7.5.1 Bayer AG Business Overview
      • 7.5.2 Bayer AG Contraceptives Drugs and Devices Quarterly Production and Revenue, 2020
      • 7.5.3 Bayer AG Contraceptives Drugs and Devices Product Introduction
      • 7.5.4 Bayer AG Response to COVID-19 and Related Developments
    • 7.6 Mayer Laboratories, Inc
      • 7.6.1 Mayer Laboratories, Inc Business Overview
      • 7.6.2 Mayer Laboratories, Inc Contraceptives Drugs and Devices Quarterly Production and Revenue, 2020
      • 7.6.3 Mayer Laboratories, Inc Contraceptives Drugs and Devices Product Introduction
      • 7.6.4 Mayer Laboratories, Inc Response to COVID-19 and Related Developments
    • 7.7 The Female Health Company
      • 7.7.1 The Female Health Company Business Overview
      • 7.7.2 The Female Health Company Contraceptives Drugs and Devices Quarterly Production and Revenue, 2020
      • 7.7.3 The Female Health Company Contraceptives Drugs and Devices Product Introduction
      • 7.7.4 The Female Health Company Response to COVID-19 and Related Developments
    • 7.8 Cooper Surgical, Inc
      • 7.8.1 Cooper Surgical, Inc Business Overview
      • 7.8.2 Cooper Surgical, Inc Contraceptives Drugs and Devices Quarterly Production and Revenue, 2020
      • 7.8.3 Cooper Surgical, Inc Contraceptives Drugs and Devices Product Introduction
      • 7.8.4 Cooper Surgical, Inc Response to COVID-19 and Related Developments
    • 7.9 Allergan plc
      • 7.9.1 Allergan plc Business Overview
      • 7.9.2 Allergan plc Contraceptives Drugs and Devices Quarterly Production and Revenue, 2020
      • 7.9.3 Allergan plc Contraceptives Drugs and Devices Product Introduction
      • 7.9.4 Allergan plc Response to COVID-19 and Related Developments
    • 7.10 Cipla Limited
      • 7.10.1 Cipla Limited Business Overview
      • 7.10.2 Cipla Limited Contraceptives Drugs and Devices Quarterly Production and Revenue, 2020
      • 7.10.3 Cipla Limited Contraceptives Drugs and Devices Product Introduction
      • 7.10.4 Cipla Limited Response to COVID-19 and Related Developments
    • 7.11 Merck & Co. Inc
      • 7.11.1 Merck & Co. Inc Business Overview
      • 7.11.2 Merck & Co. Inc Contraceptives Drugs and Devices Quarterly Production and Revenue, 2020
      • 7.11.3 Merck & Co. Inc Contraceptives Drugs and Devices Product Introduction
      • 7.11.4 Merck & Co. Inc Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Contraceptives Drugs and Devices Supply Chain Analysis
      • 8.1.1 Contraceptives Drugs and Devices Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Contraceptives Drugs and Devices Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Contraceptives Drugs and Devices Distribution Channels
      • 8.2.2 Covid-19 Impact on Contraceptives Drugs and Devices Distribution Channels
      • 8.2.3 Contraceptives Drugs and Devices Distributors
    • 8.3 Contraceptives Drugs and Devices Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Contraceptives Drugs and Devices, including the following market information:
      Global Contraceptives Drugs and Devices Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Contraceptives Drugs and Devices Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Contraceptives Drugs and Devices Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Contraceptives Drugs and Devices Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

      Key market players
      Major competitors identified in this market include Teva Pharmaceutical Industries Ltd, Church & Dwight Co. Inc, Reckitt Benckiser Plc, Pfizer, Inc, Bayer AG, Mayer Laboratories, Inc, The Female Health Company, Cooper Surgical, Inc, Allergan plc, Cipla Limited, Merck & Co. Inc, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
      Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)

      Based on the Application:
      Female
      Male

      Buy now